Affiliation:
1. Mersın City Hospital
2. ERZINCAN BINALI YILDIRIM UNIVERSITY
Abstract
Objective: This study sought to discern the differential impacts of communicating individualized breast cancer risk versus disseminating generic breast cancer information on women's proclivity towards breast cancer screenings.
Method: A structured experimental design was used, including 300 female volunteers aged between 40-69, who had not previously been diagnosed with breast cancer, in Erzincan. Data collection entailed a face-to-face administration of a 22-item questionnaire complemented by the ASSISTS scale. Participants were randomized into two conditions: one receiving a standardized briefing on breast cancer screening modalities, and the other being apprised of their lifetime risk of breast cancer development based on the modified Gail model.
Results: Post-intervention, 55.8% (n=72) of the risk-informed cohort and 40.5% (n=41) of the generic information cohort expressed a willingness to undergo screening (p=0.022). Notably, the group informed of their personalized risk exhibited a more pronounced uptick in requests for breast self-examination, clinical breast examination, and mammography screening compared to their counterparts.
Conclusion: The communication of personalized breast cancer risk proves to be a more efficacious and time-efficient strategy than generic information dissemination in bolstering screening participation rates.
Reference24 articles.
1. 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021;71(3):209-49.
2. 2. International Agency for Research on Cancer. World Cancer Day: Breast cancer overtakes lung cancer in terms of number of new cancer cases worldwide. IARC showcases key research projects to address breast cancer 2021 [12.05.2024]. Available from: https://www.iarc.who.int/wp-content/uploads/2021/02/pr294_E.pdf.
3. 3. Ginsburg O, Yip CH, Brooks A, Cabanes A, Caleffi M, Dunstan Yataco JA, et al. Breast cancer early detection: A phased approach to implementation. Cancer causes. 2020;126:2379-93.
4. 4. Tabár L, Dean PB, Chen THH, Yen AMF, Chen SLS, Fann JCY, et al. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. 2019;125(4):515-23.
5. 5. T.R. Ministry of Health Turkish Public Health Institution Cancer Department. Türkiye Cancer Control Program 2016 [cited 2023 24 January]. Available from: https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/yayinlar/Kitaplar/TURKIYE_KANSER_KONTROL_PROGRAMI_2016.pdf.